ABSTRACT The Mycoplasma phocicerebrale genome was analyzed to better understand this opportunistic pathogen. Amplification with 29 polymerase was used to generate enough genomic DNA for large-insert library construction. Like other mycoplasmas from seals, M. phocicerebrale encodes an immunosuppressor that may predispose susceptibility to infection or influence intercurrent diseases of affected hosts.
protein, carbohydrate, fatty acid, or phospholipid metabolism; transport or binding factors; and cell division factors. The genome amplification approach to library construction precluded inferences from the SEQUEL subreads regarding base methylation, but the annotation of cytosine 5-methyltransferase and type II restriction-modification methylase genes is evidence that the genome undergoes epigenetic modification.
M. phocicerebrale encodes one protein (DMC14_000785) with about 60% amino acid sequence similarity to the three orthologs of mycoplasmal protein M of Mycoplasma phocirhinis and about 40% similarity to the four orthologs of mycoplasmal protein M of Mycoplasma phocidae (11, 12) . Protein M binds host IgG to block antigen-specific binding (13) . No other determinants of tropism or virulence were discerned by genome analysis, although adherence and cytotoxicity of M. phocicerebrale to epithelial cells has been demonstrated in vitro (14) . Immunosuppression may constitute a mechanism that enables M. phocicerebrale to evade host defenses or modulate intercurrent diseases of affected individuals (15) (16) (17) (18) .
Data availability. The M. phocicerebrale 1049 T genome sequence and annotation have been deposited in GenBank under the accession number CP033058 and assembly accession number GCA_003383595; the assembly described in this paper is the latest version, ASM338359v3. The raw data are available in the NCBI Sequence Read Archive linked to BioProject accession number PRJNA473817.
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